Literature DB >> 22328717

The unliganded glucocorticoid receptor positively regulates the tumor suppressor gene BRCA1 through GABP beta.

Heather D Ritter1, Lilia Antonova, Christopher R Mueller.   

Abstract

Loss of BRCA1 tumor suppressor function is a critical event in breast tumorigenesis. We have previously identified the stress hormone hydrocortisone as a negative regulator of BRCA1 expression in nonmalignant mammary cells. Here, we have identified a direct role for the unliganded glucocorticoid receptor (GR) in BRCA1 upregulation in the absence of hydrocortisone. The positive regulatory effect of GR is lost upon the addition of hydrocortisone. We have shown that GR interacts with the BRCA1 promoter only in the absence of hydrocortisone, and that this interaction is mediated through the β-subunit of the ets transcription factor GA-binding protein (GABP) at the RIBS promoter element. GR and GABPβ interact in both coimmunoprecipitation and mammalian two-hybrid assays, and this interaction involves the N-terminal to central regions of both proteins. This work presents the first evidence of a ligand-independent role for GR as a positive regulator of gene expression, and loss of GR from the BRCA1 promoter in response to stress hormones leads to decreased BRCA1 expression. Because low levels of BRCA1 have been implicated in the development of sporadic breast cancer, this may represent a novel mechanism through which prolonged stress signaling increases breast cancer risk.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22328717     DOI: 10.1158/1541-7786.MCR-11-0423-T

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  27 in total

1.  Environment and genetics: Making sense of the noise.

Authors:  Anna Petherick
Journal:  Nature       Date:  2012-05-30       Impact factor: 49.962

2.  Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats.

Authors:  Leandro F Vendruscolo; Estelle Barbier; Joel E Schlosburg; Kaushik K Misra; Timothy W Whitfield; Marian L Logrip; Catherine Rivier; Vez Repunte-Canonigo; Eric P Zorrilla; Pietro P Sanna; Markus Heilig; George F Koob
Journal:  J Neurosci       Date:  2012-05-30       Impact factor: 6.167

Review 3.  The Two Faces of Adjuvant Glucocorticoid Treatment in Ovarian Cancer.

Authors:  Vladimir Djedovic; Yoo-Young Lee; Alexandra Kollara; Taymaa May; Theodore J Brown
Journal:  Horm Cancer       Date:  2018-01-08       Impact factor: 3.869

Review 4.  The ETS family of oncogenic transcription factors in solid tumours.

Authors:  Gina M Sizemore; Jason R Pitarresi; Subhasree Balakrishnan; Michael C Ostrowski
Journal:  Nat Rev Cancer       Date:  2017-04-28       Impact factor: 60.716

5.  Two Pioneer Transcription Factors, Krüppel-Like Transcription Factor 4 and Glucocorticoid Receptor, Cooperatively Transactivate the Bovine Herpesvirus 1 ICP0 Early Promoter and Stimulate Productive Infection.

Authors:  Fouad S El-Mayet; Laximan Sawant; Prasanth Thunuguntla; Jing Zhao; Clinton Jones
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

6.  Transactivation of Herpes Simplex Virus 1 (HSV-1) Infected Cell Protein 4 Enhancer by Glucocorticoid Receptor and Stress-Induced Transcription Factors Requires Overlapping Krüppel-Like Transcription Factor 4/Sp1 Binding Sites.

Authors:  Jeffery B Ostler; Prasanth Thunuguntla; Bailey Y Hendrickson; Clinton Jones
Journal:  J Virol       Date:  2021-01-28       Impact factor: 5.103

7.  Overexpression of SASH1 related to the decreased invasion ability of human glioma U251 cells.

Authors:  Liu Yang; Mei Liu; Zhikai Gu; Jianguo Chen; Yaohua Yan; Jian Li
Journal:  Tumour Biol       Date:  2012-08-23

8.  Differential subcellular localization of the glucocorticoid receptor in distinct neural stem and progenitor populations of the mouse telencephalon in vivo.

Authors:  Maria A Tsiarli; A Paula Monaghan; Donald B Defranco
Journal:  Brain Res       Date:  2013-06-07       Impact factor: 3.252

Review 9.  Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy.

Authors:  Janet P Hapgood; Chanel Avenant; Johnson M Moliki
Journal:  Pharmacol Ther       Date:  2016-06-08       Impact factor: 12.310

10.  Frequent promoter hypermethylation and expression reduction of the glucocorticoid receptor gene in breast tumors.

Authors:  Kirsten A Nesset; Ami M Perri; Christopher R Mueller
Journal:  Epigenetics       Date:  2014-03-12       Impact factor: 4.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.